Shanghai Junsai Biotechnology Co., Ltd
君赛生物
Shanghai Junsai Biotechnology Co., Ltd
Biotech/Healthcare
An innovative company in the emerging field of cell therapies for solid tumors, focused on developing novel solid-tumor therapies and first-in-class or best-in-class cell therapy drugs based on tumor-infiltrating lymphocytes (TILs), covering multiple relapsed and refractory cancers.
Latest round: Series C (2025)
Source: ChinaBulls — chinabulls.com
Last updated 2025-08-01
Funding history
Request access to view this section.
Investors
Request access to view this section.
HQ & website
Request access to view this section.
Tags
Request access to view this section.